 SALT LAKE CITY, Feb. 7, 2022 PRNewswire -- Sera Prognostics Inc., The Pregnancy Company Nasdaq: SERA, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the upcoming virtual BTIG MedTech, Digital Health, Life Science Diagnostic Tools Conference and the virtual Citi 2022 Healthcare Conference: Services, MedTech, Life Science Tools HCIT. Gregory C. 